Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nobuko Hijiya & Michael J Mauro. (2023) Asciminib in the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia: Focus on Patient Selection and Outcomes. Cancer Management and Research 15, pages 873-891.
Read now
Read now
Articles from other publishers (3)
E. I. Kolgaeva, M. Yu. Drokov & D. E. Vybornykh. (2023) Treatment adherence in patients with blood system diseases and recipients of allogeneic organs and tissues. Oncohematology 18:1, pages 132-141.
Crossref
Crossref
Ana Isabel Cachafeiro Pin, Laura Villaverde Piñeiro, Susana Martín Clavo & Martha Milena Silva Castro. (2023) [Translated article] The needs and medication experience of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: A systematic review. Farmacia Hospitalaria 47:2, pages T85-T92.
Crossref
Crossref
Nur Hezrin Shahrin, Carol Wadham & Susan Branford. (2022) Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication. Current Hematologic Malignancy Reports 17:6, pages 171-180.
Crossref
Crossref